Dimmi Life Holdings Limited AI Stock Analysis
Want to see HK:1667 full AI Analyst Report?
Dimmi Life Holdings Limited (1667) AI Stock Analysis
Dimmi Life Holdings Limited
(HKEX:1667)
The score is driven primarily by structurally weak profitability, persistent cash burn, and high leverage. Technical positioning provides a moderate offset because the price is above all listed moving averages and MACD is positive, but the negative P/E and absent dividend support keep the overall score low.
Dimmi Life Holdings Limited (1667) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 312.00M
- Dividend Yield
- ―
- Average Volume (3M)
- 75.22K
- Price to Earnings (P/E)
- -8.1
- Beta (1Y)
- 0.66
- Revenue Growth
- -19.64%
- EPS Growth
- 38.89%
- Country
- Hong Kong
- Employees
- 47
- Sector
- General
- Sector Strength
- 55
- Industry
- Engineering & Construction
Dimmi Life Holdings Limited Business Overview & Revenue Model
Company Description
Dimmi Life Holdings Limited operates as an investment holding firm, primarily concentrating on the construction industry within Hong Kong. Its core services encompass new building development, alterations, additions, interior fit-out projects, genera...
Dimmi Life Holdings Limited Financial Statement Overview
Summary
Persistent heavy losses, shrinking revenue, negative operating and free cash flow, high leverage, and severely eroded equity place financial performance at the minimum score.
Income Statement
8Very NegativeBalance Sheet
12Very NegativeCash Flow
6Very Negative| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.08M | 82.08M | 102.13M | 121.52M | 109.33M | 120.52M |
| Gross Profit | 304.00K | 777.00K | -7.45M | 2.05M | 4.01M | -222.00K |
| EBITDA | -40.42M | -39.94M | -60.38M | -75.66M | -12.18M | -39.82M |
| Net Income | -26.52M | -44.36M | -72.58M | -90.42M | -26.64M | -60.49M |
Balance Sheet | ||||||
| Total Assets | 190.47M | 190.47M | 250.12M | 278.50M | 321.65M | 313.53M |
| Cash, Cash Equivalents and Short-Term Investments | 13.33M | 13.33M | 7.47M | 9.72M | 13.89M | 10.17M |
| Total Debt | 103.44M | 103.44M | 154.13M | 171.85M | 121.17M | 100.36M |
| Total Liabilities | 179.96M | 179.96M | 235.69M | 260.68M | 311.39M | 282.02M |
| Stockholders Equity | 10.51M | 10.51M | 14.43M | 17.82M | 10.26M | 31.51M |
Cash Flow | ||||||
| Free Cash Flow | -15.37M | -15.37M | -29.48M | -39.87M | -20.48M | -38.98M |
| Operating Cash Flow | -14.45M | -14.45M | -29.28M | -38.45M | -20.21M | -38.96M |
| Investing Cash Flow | 21.45M | 21.45M | -5.57M | 26.00K | 14.77M | 33.06M |
| Financing Cash Flow | -1.10M | -1.10M | 32.49M | 34.14M | 8.96M | -983.00K |
Dimmi Life Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1667, the sentiment is Positive. The current price of 0.38 is above the 20-day moving average (MA) of 0.37, above the 50-day MA of 0.36, and above the 200-day MA of 0.36, indicating a bullish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 53.96 is Neutral, neither overbought nor oversold. The STOCH value of 59.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1667.
Dimmi Life Holdings Limited Peers Comparison
Overall Rating
HK:214571Outperform
HK:988656Neutral
HK:015745Neutral
HK:166745Neutral
HK:213841Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | HKD 9.46B | 12.36 | 25.77% | 6.00% | 23.19% | -22.44% | |
| 56Neutral | HKD 1.05B | -15.22 | -3.87% | ― | 8.73% | 80.38% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 45Neutral | HKD 850.89M | -16.03 | -12.81% | ― | 13.43% | 7.72% | |
| 45Neutral | HKD 364.80M | -8.08 | -195.22% | ― | -19.64% | 38.89% | |
| 41Neutral | HKD 651.87M | -1.73 | -25.36% | ― | -8.94% | -140.82% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:1667 | Dimmi Life Holdings Limited | 0.38 | 0.02 | 4.17% | |
| HK:0157 | Natural Beauty Bio-Technology | 0.46 | -0.05 | -9.80% | |
| HK:9886 | Dingdang Health Technology Group Ltd. | 0.88 | -0.29 | -24.79% | |
| HK:2138 | EC Healthcare | 0.58 | -0.07 | -10.00% | |
| HK:2145 | Shanghai Chicmax Cosmetics Co., Ltd. Class H | 23.38 | -59.18 | -71.68% | |
| HK:6883 | Eternal Beauty Holdings Limited | 2.03 | 0.05 | 2.53% |
Dimmi Life Holdings Limited Corporate Events
Dimmi Life Wins Unanimous Shareholder Support for Capital Mandates at AGM
Dimmi Life Holdings Limited reported that all resolutions at its annual general meeting on 30 September 2026 were approved by poll with unanimous support from voting shareholders. Shareholders received the audited financial statements for the year en...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
